AR016650A1 - UNA COMPOSICION FARMACEUTICA PARA ADMISTRACIoN VAGINAL Y SU USO - Google Patents

UNA COMPOSICION FARMACEUTICA PARA ADMISTRACIoN VAGINAL Y SU USO

Info

Publication number
AR016650A1
AR016650A1 ARP980104558A AR016650A1 AR 016650 A1 AR016650 A1 AR 016650A1 AR P980104558 A ARP980104558 A AR P980104558A AR 016650 A1 AR016650 A1 AR 016650A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical composition
beta
adrenergic receptor
treating agent
bioadhesive
Prior art date
Application number
Other languages
English (en)
Spanish (es)
Original Assignee
Columbia Lab Bermuda Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Columbia Lab Bermuda Ltd filed Critical Columbia Lab Bermuda Ltd
Publication of AR016650A1 publication Critical patent/AR016650A1/es

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ARP980104558 1997-09-12 1998-09-14 UNA COMPOSICION FARMACEUTICA PARA ADMISTRACIoN VAGINAL Y SU USO AR016650A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5878997P 1997-09-12 1997-09-12

Publications (1)

Publication Number Publication Date
AR016650A1 true AR016650A1 (es) 2001-07-25

Family

ID=22018939

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980104558 AR016650A1 (es) 1997-09-12 1998-09-14 UNA COMPOSICION FARMACEUTICA PARA ADMISTRACIoN VAGINAL Y SU USO

Country Status (7)

Country Link
AR (1) AR016650A1 (fr)
MA (1) MA26546A1 (fr)
MY (1) MY116275A (fr)
PE (1) PE119299A1 (fr)
RU (1) RU2219905C2 (fr)
UA (1) UA62983C2 (fr)
ZA (1) ZA988328B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6479045B2 (en) 1999-12-22 2002-11-12 Columbia Laboratories, Inc. Vaginal pH buffering for preventing miscarriage and premature labor, by treating or preventing bacterial vaginosis
RU2578476C1 (ru) * 2015-03-31 2016-03-27 государственное бюджетное образовательное учреждение высшего профессионального образования"Пермский государственный медицинский университет имени академика Е.А. Вагнера" Министерства здравоохранения Российской Федерации Способ лечения угрожающих преждевременных родов

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5397771A (en) * 1990-05-10 1995-03-14 Bechgaard International Research And Development A/S Pharmaceutical preparation
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles

Also Published As

Publication number Publication date
RU2219905C2 (ru) 2003-12-27
MY116275A (en) 2003-12-31
MA26546A1 (fr) 2004-12-20
ZA988328B (en) 1999-02-23
UA62983C2 (en) 2004-01-15
PE119299A1 (es) 1999-12-01

Similar Documents

Publication Publication Date Title
AR005281A1 (es) Composicion farceutica oral , procedimientos para su manufactura y uso de esa composicion farmaceutica para la preparacion de medicamentos. .
CU23226B7 (es) COMPOSICIONES ANALGéSICAS QUE COMPRENDEN COMPUESTOS ANTI-EPILéPTICOS Y ANTINFLAMATORIOS NO ESTEROIDEOS
DE69826644D1 (de) Topische pharmazeutische zusammensetzung, enthaltend einen cholinergischen wirkstoff oder einen kalziumkanalblocker
BR0109150A (pt) Método para administração de um anestésico local a um indivìduo em necessidade de um efeito anestésico local, emplastro, composição, e, recipiente
CO5680108A1 (es) Compuestos para el tratamiento de la disfuncion sexual femenina
ES2156839T1 (es) Medicamento que contiene alginato e implante para tratar la fibrosis.
BR9808888A (pt) Formas de dosagem e método de melhorar disfunção erétil masculina
AR002355A1 (es) Composiciones y metodos para administracion local de agentes farmaceuticamente activos.
CO5560558A2 (es) Uso de una composicion de celecoxib para rapido alivio del dolor
EP0957914A4 (fr) Formulation d'agonistes de 5-ht
CO5200837A1 (es) Vacunas
WO1998056323A1 (fr) Dispositif et procede de traitement de la dysmenorrhee
AR037255A1 (es) Composiciones farmaceuticas que contienen oxibutinina
ES2043025T3 (es) Un procedimiento para preparar una composicion farmaceutica que contiene acido 3-(aminopropil)metil-fosfinico como agente terapeutico.
SE0002754D0 (sv) New pharmaceutical combination formulation and method of treatment with the combination
CY2562B1 (en) Pharmaceutical injectable solution of paracetamol and combinations of paracetamol with other active substances
PT770384E (pt) Composicoes farmaceuticas solidas anidras para utilizacao vaginal
AR033031A1 (es) Tratamiento usando polipeptidos de neublastina
AR019699A1 (es) Composicion farmaceutica para el tratamiento de disfuncion de la evacuacion y uso de la misma para la preparacion de un agente terapeutico
CA2245890A1 (fr) Utilisation d'extrait de cimicifuga racemosa
CO5570661A2 (es) Combinaciones que comprenden inhibidores de cox-2 y aspirina
AR003921A1 (es) Combinacion activa farmaceutica
CA2156481A1 (fr) Compositions antagonistes du recepteur 5-ht2, utiles pour le traitement des troubles veineux
ES2157107T3 (es) Uso de moxonidina para el tratamiento del dolor neuropatico.
CO5200833A1 (es) Regimenes de dosificacion para lasofoxifeno

Legal Events

Date Code Title Description
FG Grant, registration
FG Grant, registration